Tylicki Leszek, Manitius Jacek, Łysiak-Szydłowska Wiesława, Rutkowski Bolesław
Department of Nephrology, Medical University, Gdańsk, Poland.
Med Sci Monit. 2003 Apr;9(4):CR135-41.
Tubular injury is an important component of hypertensive nephropathy, but its pathogenesis is not completely clear. We attempted to determine whether tubular injury precedes glomerular involvement, and to evaluate the role of vascular damage and metabolic disturbances in this process.
MATERIAL/METHODS: 25 patients with newly diagnosed primary non-treated hypertension without microalbuminuria were studied. 15 healthy volunteers served as controls. We measured total urine activity of N-acetyl-beta-D-glucosaminidase (NAG) as a marker of tubular injury, albumin excretion, serum concentrations of insulin, uric acid and lipids. Intravenous glucose tolerance tests and oral fructose loading tests were performed to assess carbohydrate and purine metabolism. The plasma glucose area (PGA) under the curve of glucose levels obtained from the former test was calculated, as well as the plasma uric acid area (PUAA) under the curve of uric acid levels from the latter. Hypertensive vascular injury was investigated by direct ophthalmoscopy.
Significantly higher NAG activity was found in hypertensives in comparison with healthy controls. NAG activity was not influenced by the extent of ophthalmoscopically detectable vascular injury. We found positive correlation between urine NAG activity and PGA. A borderline significant association was also found between NAG activity and PUAA in hypertensive patients.
Our results suggest that tubular injury is present in the early stages of hypertensive nephropathy and may precede glomerular damage. Ischemia due to changes in small vessels may not be the only factor responsible for this injury. Metabolic disturbances, especially carbohydrate abnormalities, may also play a role.
肾小管损伤是高血压肾病的重要组成部分,但其发病机制尚不完全清楚。我们试图确定肾小管损伤是否先于肾小球受累,并评估血管损伤和代谢紊乱在此过程中的作用。
材料/方法:研究了25例新诊断的未经治疗的原发性高血压且无微量白蛋白尿的患者。15名健康志愿者作为对照。我们测量了尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)的总活性作为肾小管损伤的标志物、白蛋白排泄量、胰岛素、尿酸和脂质的血清浓度。进行静脉葡萄糖耐量试验和口服果糖负荷试验以评估碳水化合物和嘌呤代谢。计算前一项试验获得的葡萄糖水平曲线下的血浆葡萄糖面积(PGA),以及后一项试验尿酸水平曲线下的血浆尿酸面积(PUAA)。通过直接检眼镜检查研究高血压血管损伤。
与健康对照相比,高血压患者的NAG活性显著更高。NAG活性不受检眼镜可检测到的血管损伤程度的影响。我们发现尿NAG活性与PGA之间呈正相关。在高血压患者中,NAG活性与PUAA之间也发现了临界显著关联。
我们的结果表明,肾小管损伤存在于高血压肾病的早期阶段,可能先于肾小球损伤。小血管变化引起的缺血可能不是造成这种损伤的唯一因素。代谢紊乱,尤其是碳水化合物异常,也可能起作用。